Provided by Tiger Fintech (Singapore) Pte. Ltd.

Olema Pharmaceuticals, Inc.

4.11
-0.0300-0.72%
Post-market: 4.310.2000+4.87%17:52 EDT
Volume:1.10M
Turnover:4.65M
Market Cap:304.98M
PE:-1.80
High:4.75
Open:4.57
Low:4.10
Close:4.14
Loading ...

Olema Pharmaceuticals Price Target Cut to $25.00/Share From $30.00 by Oppenheimer

Dow Jones
·
6 hours ago

Olema Pharmaceuticals, Inc. : Oppenheimer Cuts Target Price to $25 From $30

THOMSON REUTERS
·
Yesterday

Olema Pharmaceuticals Inc reports results for the quarter ended December 31 - Earnings Summary

Reuters
·
Yesterday

Promising Clinical Data and Market Opportunities Drive Buy Rating for Olema Pharmaceuticals

TIPRANKS
·
Yesterday

Oppenheimer Remains a Buy on Olema Pharmaceuticals (OLMA)

TIPRANKS
·
Yesterday

Olema Pharmaceuticals Q4 Net Loss Widens

MT Newswires Live
·
Yesterday

Olema Pharmaceuticals Q4 2024 GAAP EPS $(0.51) Beats $(0.63) Estimate

Benzinga
·
Yesterday

BRIEF-Olema Oncology Q4 Net Income USD -33.567 Million

Reuters
·
Yesterday

Olema Oncology Q4 Income From Operations USD -36.768 Million

THOMSON REUTERS
·
Yesterday

Press Release: Olema Oncology Reports Fourth Quarter and Full Year 2024 Financial and Operating Results

Dow Jones
·
Yesterday

Olema Pharmaceuticals Inc expected to post a loss of 64 cents a share - Earnings Preview

Reuters
·
17 Mar

Olema Pharmaceuticals Price Target Maintained With a $30.00/Share by HC Wainwright & Co.

Dow Jones
·
12 Mar

Promising Efficacy of Olema Pharmaceuticals’ Palazestrant Supports Buy Rating

TIPRANKS
·
11 Mar

Olema Pharmaceuticals: Promising Clinical Results and Strong Financial Health Support Buy Rating

TIPRANKS
·
07 Mar

Olema Pharmaceuticals (OLMA) Receives a Buy from Oppenheimer

TIPRANKS
·
06 Mar

Olema Pharmaceuticals Price Target Maintained With a $30.00/Share by HC Wainwright & Co.

Dow Jones
·
06 Mar